Medical/Pharmaceuticals Newswire
CORRECTING and REPLACING AMAG Pharmaceuticals, Inc. to Present at the Jefferies 2nd Annual Healthcare Conference
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - In first graph, first sentence of release, the date should read: Wednesday, June 25 (sted Thursday June, 25). The corrected release reads: AMAG PHARMACEUTICALS, INC. TO PRESENT AT THE JEFFERIES 2ND ANNUAL HEALTHCARE CONFERENCE AMAG Pharmaceuticals...
Healthways Reports 34% Growth in Earnings to $0.39 per Diluted Share for the Third Quarter of Fiscal 2008
NASHVILLE, Tenn.-(Business Wire)-June 18, 2008 - Ben R. Leedle, Jr., president and chief executive officer of Healthways, Inc. (NASDAQ: HWAY), today announced financial results for the third quarter of fiscal 2008, ended May 31, 2008. Total revenues for the quarter were $191.4 million, a 14...
CombinatoRx to Present at the Third Annual Piper Jaffray Europe Conference
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that Alexis Borisy, President and CEO, is scheduled to present at the upcoming Third Annual Piper Jaffray Europe Conference at the ANdAZ Hotel in London. Mr. Borisy is scheduled to present on...
Alnylam to Webcast Presentation at the 2008 Piper Jaffray Europe Conference
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2008 Piper Jaffray Europe Conference on Wednesday, June 25, 2008, at 10:20 a.m. BST (5:20 a.m...
CEO Tapped as Thought Leader to Speak at Two Most Important Life Science Conferences of 2008
DURHAM, N.C.-(Business Wire)-June 18, 2008 - InfoStrength(R), Inc. launches pre-configured and validated on-demand Smart Solutions at Bio 2008 and 44th DIA Annual Meeting. "InfoStrength is very pleased to be featured in the BioProcess Zone Theater at Bio 2008 and at the 44th DIA Annual Meeting in...
Biovail Announces That a Second Proxy Advisory Firm Recommends Shareholders Vote for Biovail's Director Nominees
TORONTO-(Business Wire)-June 18, 2008 - Biovail Corporation (NYSE: BVF) (TSX: BVF) today announced that PROXY Governance, Inc., a leading independent proxy advisory firm, recommends that Biovail shareholders vote FOR the Company's slate of director nominees at the upcoming Annual Meeting of...
More Than Half of Hispanic Boomers Like to Consider Alternative Health Treatments According to a New Report from Focalyst
NEW YORK-(Business Wire)-June 18, 2008 - Hispanic Boomers' perceptions of healthcare and health information differ significantly from those of the General Market Boomer according to a new report from Focalyst, "A Continued Look at Diversity Among Hispanic Boomers." The report focuses on the 7...
AMRI to Present at Jefferies 2nd Annual Healthcare Conference
ALBANY, N.Y.-(Business Wire)-June 18, 2008 - AMRI (NASDAQ: AMRI) announced today that a member of senior management will present and provide an audio webcast of its corporate presentation at the Jefferies 2nd Annual Healthcare Conference at 8 a.m. Eastern Time on Wednesday, June 25, 2008. The...
NPS Pharmaceuticals to Present at Jefferies Healthcare Conference
BEDMINSTER, N.J.-(Business Wire)-June 18, 2008 - NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the Jefferies 2nd Annual Healthcare Conference in New York on Thursday, June 26, 2008 at 8:30 a.m...
MFIC Corporation Changes Name to Microfluidics International Corporation
NEWTON, Mass.-(Business Wire)-June 18, 2008 - MFIC Corporation (OTCBB: MFIC) today announced that at the Company's Annual Meeting held on June 17, 2008 shareholders voted to changes the Company's name to Microfluidics International Corporation, effective June 18, 2008. The Company's stock will...
Inotek Commences Phase 1 Trial in Glaucoma with Selective Adenosine 1 (A1) Agonist
BEVERLY, Mass.-(Business Wire)-June 18, 2008 - Inotek Pharmaceuticals Corporation announced today that it has begun enrollment in a Phase 1 clinical trial with the Company's selective Adenosine 1 agonist, INO-8875, for the treatment of glaucoma. In March, Inotek received approval from the U.S...
Latest Report Provides the Names and Affiliated Institutions of the Most Influential Key Opinion Leaders in the US Breast Cancer Market
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets VIII. About the Underlying KOL Report IX. About the Author X. Appendix - Further Charts & Rankings Companies Mentioned: — Dana-Farber Cancer Institute — Harvard Medical School — Harvard Public School of...
Secrets of Sharks Unlocked to Save Lives in Victoria, Australia
SAN DIEGO-(Business Wire)-June 18, 2008 - New technology pioneered by scientists in Victoria, Australia is turning sharks into life savers. Victoria's Premier, John Brumby, today announced today at the BIO International Convention that scientists working at La Trobe University were pioneering a...
SMI Launches Patient Recruitment Arm to Increase Enrollment in Clinical Trials
KING OF PRUSSIA, Pa.-(Business Wire)-June 18, 2008 - SMI announced today the launch of SMI Clinical Trials, a patient recruitment division designed to accelerate the clinical trial recruitment and enrollment process and reduce per-patient recruitment costs. SMI is an out-of-home marketing firm...
Type-2 Diabetes Competitive Intelligence Report Offered by Austin Research Group
PLEASANTON, Calif.-(Business Wire)-June 18, 2008 - It is estimated that diabetes affects more than 18 million people in the United States and approximately 194 million adults worldwide. The World Health Organization projects that the number of people with diabetes will double to 366 million by 2030...
Majority of Americans Support Legislative Action to Disclose Pharmaceutical Company Gifts to Physicians
BOSTON-(Business Wire)-June 18, 2008 - A majority of Americans (64%) say that it is important to know their physician's financial ties to pharmaceutical companies and 68% would support legislation requiring pharmaceutical companies to disclose gifts to doctors, according to the results of a new...
MedeFile International Teams with Newark Fraternal Order of Police
CEDAR KNOLLS, N.J., June 18 PRNewswire-FirstCall — MedeFile International, Inc. (OTC Bulletin Board: MDFI), a company specializing in portable electronic medical records management solutions, today announced that in collaboration with the Newark Fraternal Order of Police (NFOP), Lodge...
Patient Safety Authority Supports 'National Time Out Day'
The Authority continues monitoring and evaluating wrong-site surgeries with the numbers remaining steady; releases preview of wrong-site surgery update HARRISBURG, Pa., June 18 PRNewswire-USNewswire — The Pennsylvania Patient Safety Authority today supports "National Time Out Day...
Research and Markets: A SWOT Framework Analysis of Schering-Plough Corporation Completes This In-Depth Company Analysis
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets has announced the addition of the "Analysis of Schering-Plough Corporation" companyprofile to their offering. We present Analysis of Schering-Plough Corporation. A complete and comprehensive analysis of Schering-Plough Corporation...
Ethisphere Institute Names SCA to List of Top Ethical Companies
PHILADELPHIA, June 18 PRNewswire — The Ethisphere Institute has selected SCA, the global parent company of SCA Personal Care, from among 5,000 companies for inclusion in its 2008 World's Most Ethical Companies list. The Ethisphere Institute — a think-tank dedicated to the research...
Research and Markets: Diabetes Drug Delivery and Diagnostics Leaning Towards the Non-invasive Revolution
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets has announced the addition of the "Pipeline Insight: Diabetes Drug Delivery and Diagnostics - Towards the Non-invasive Revolution" report to their offering. The combined type 1 and type 2 diabetes mellitus population in the seven...
U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R)
CAMBRIDGE, Mass., June 18 PRNewswire-FirstCall — Biopure Corporation (Nasdaq: BPUR) announced today that the U.S. Naval Medical Research Center (NMRC) has submitted a new protocol for review by the Food and Drug Administration (FDA) for a Phase 2 clinical trial of Hemopure(R...
Incentives to Develop Medicines for Neglected Diseases Highlighted at 2008 BIO International Convention
WASHINGTON-(Business Wire)-June 18, 2008 - The Biotechnology Industry Organization (BIO) announced today the release of a paper outlining incentives to encourage innovation for neglected diseases. The paper, written by BIO's health economist Ted Buckley, PhD, is being released during the 2008 BIO...
Northwest Run/Walk for Epilepsy - Spokane
Saturday event in Spokane benefits people living with seizures SPOKANE, Wash., June 18 PRNewswire-USNewswire — The Epilepsy Foundation Northwest announces the Northwest Run/Walk for Epilepsy to be held this Saturday, June 21 in Spokane at Riverfront Park near the Northbank Picnic area...
Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
SOUTH SAN FRANCISCO, Calif., June 18 PRNewswire-FirstCall — Exelixis, Inc. (Nasdaq: EXEL) announced today that Frank Karbe, executive vice president and chief financial officer at Exelixis, will present at the Piper Jaffray Europe Conference at 3:40 a.m. PT/6:40 a.m. ET/11:40 a.m...
Millipore Corporation Awards Grant to Scientist at Scripps Research Institute of California
BILLERICA, Mass.-(Business Wire)-June 18, 2008 - Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Jeanne Loring, Ph.D. a $150,000 grant for her work in stem cell research...
Build and Maintain an Effective Competitive Intelligence Group
CHAPEL HILL, N.C., June 18 PRNewswire — A CI head once noted that, "Competitive Intelligence is like oxygen. You have to have it, but the only time you realize you need it is when it is in short supply." In today's marketing space, most companies need competitive intelligence to...
Low Levels of Diagnosis and New Biological Approaches to Treatment Indicate a Positive Future for Gastrointestinal Drugs
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets reach the market first? Key Topics Covered: - The IBD therapy market - IBD management - Current treatment options - Potential new drugs for IBD - Sales forecast - Competition within the marketplace - Risks associated with drug...
Hologic to Present at the Jefferies 2nd Annual Healthcare Conference
BEDFORD, Mass., June 18 PRNewswire-FirstCall — Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Jefferies 2nd Annual Healthcare Conference being held June 24 - 26, 2008, at the Mandarin Oriental Hotel in New York, NY...
Boehner Thanked for Opposing Funding Cut to Medicare Beneficiaries
Congressman Expresses Concern Over Looming Skilled Nursing Facility Funding Cut COLUMBUS, Ohio, June 18 PRNewswire-USNewswire — The Ohio Health Care Association (OHCA) and the American Health Care Association (AHCA) today praised Ohio Congressman and Republican Leader John Boehner...
World Renowned Hand Surgeon Helps Patients 'Conquer' Joint Discomfort Naturally
LEXINGTON, Ky., June 18 PRNewswire — Renowned surgeon and co-founder of Kleinert Kutz Hand Care Center in Louisville, KY, Dr. Joseph E. Kutz has specialized in hand and reconstructive microsurgery for over four decades. Every year he sees a tremendous number of patients, from youths...
bioMerieux Increases its Lead in Microbiology with the Acquisition of the Swedish Diagnostics Specialist AB BIODISK
MARCY L'ETOILE, France-(Business Wire)-June 18, 2008 - bioMerieux, a world leader in the field of in vitro diagnostics has concluded an agreement to acquire the privately held AB BIODISK, a Swedish in vitro diagnostics company with facilities for research and development, manufacturing and marketing...
Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
NEW YORK, June 18 PRNewswire-FirstCall — Immtech Pharmaceuticals (AMEX: IMM) and Beijing Capital Medical University (BCMU) in Beijing, one of China's leading academic medical research centers, today announced that they have signed a Memorandum of Understanding to develop a joint venture...
Johnson & Johnson Nordic AB Acquires Amic
SOLLENTUNA, Sweden, June 18 PRNewswire — Johnson & Johnson Nordic AB, a Johnson & Johnson company, today announced the acquisition of Amic, a privately held Swedish developer of in vitro diagnostic (IVD) technologies for use in Point-of-Care (POC) and near-patient settings...
CORRECTING and REPLACING Fastest Growing Medical GPO in North America Signs Greatly Expanded Contract Agreement with Cook Medical
BLOOMINGTON, Ind.-(Business Wire)-June 18, 2008 - Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: HEALTHTRUST PURCHASING GROUP SIGNS CONTRACTS WITH COOK MEDICAL HealthTrust Purchasing Group Members to Have Access to Wider...
YORK Label Poised for Continued Growth with New Equity Partner
OMAHA, Neb., June 18 PRNewswire — YORK Label CEO Rich Egan announced today that LabelCorp Holdings, Inc. ("YORK Label") has partnered with a new private equity sponsor, Diamond Castle Holdings, LLC of New York. Diamond Castle, in partnership with YORK's Senior Management Team, has...
BIO 2008: Germany on Cutting Edge in Biomanufacturing
SAN DIEGO, California, June 18 PRNewswire — Germany is on the cutting edge in biotechnology R&D and is a top player in large- and clinical-scale production. Companies located in Germany are poised to profit from the latest developments in biomanufacturing. These were the results...
BIO 2008: Germany on Cutting Edge in Biomanufacturing
SAN DIEGO, California, June 18 PRNewswire — Germany is on the cutting edge in biotechnology R&D and is a top player in large- and clinical-scale production. Companies located in Germany are poised to profit from the latest developments in biomanufacturing. These were the results...
Pioneering Solutions To Fight Staph, MRSA Infections in Sports Facilities and Synthetic Turf Fields
CLEVELAND, June 18 PRNewswire — In response to the growing number of Staph and MRSA cases in athletes, Pioneer Athletics has partnered with mPact Environmental Solutions to offer advanced antimicrobial solutions for sports facilities and synthetic turf fields. GamePlan4Sports is an...
Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO'08
SAN DIEGO, June 18 PRNewswire — Kansas researchers and companies excel in the human health biosciences, and $3.7 million in new Kansas Bioscience Authority (KBA) investments in that sector will support cutting-edge innovations for the treatment of cancer, HIV, and osteoporosis, as...
Immtech Reports Fiscal Year End 2008 Results
NEW YORK, June 18 PRNewswire-FirstCall — Immtech Pharmaceuticals, Inc. (Amex: IMM) today announced results for its fiscal year ended March 31, 2008. For the fiscal year ended March 31, 2008, revenues increased to $9,717,000, as compared to $4,318,000 for the fiscal year ended March...
''Super-Antioxidant'' Study to Examine Relationship between Anti-Aging and Skin's Natural Ability to Rejuvenate at the Cellular Level
GREENWOOD VILLAGE, Colo.-(Business Wire)-June 18, 2008 - A new "Super-Antioxidant" study hopes to prove that the fountain of youth is on the horizon, thanks to advances in anti-aging that are attributed to regenerating skin at the cellular level. A team of researchers, led by Dr. Kimberly Stone...
Recent Developments for Drugs, Devices and Diagnostics for the Brain and Nervous System Explored in New Neurotechnology Industry Report
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets and public neurotech stock performance - 16 brain and nervous system illness markets analyzed including: addiction, Alzheimer's disease, anxiety, attention disorders, depression, epilepsy, hearing loss, insomnia, mild cognitive...
SCAI Creates New Council for Rising Interest in Interventional Therapies for Structural Heart Disease
WASHINGTON, June 18 PRNewswire — To develop first-of-its-kind guidelines and training standards for the emerging interventional cardiology subspecialty field of structural heart disease, the Society for Cardiovascular Angiography and Interventions (SCAI) announced today the creation...
Employees with Greater Health Risks More Likely than Healthier Colleagues to Sign Up for Health Coaching Programs
NASHVILLE, Tenn.-(Business Wire)-June 18, 2008 - Gordian Health Solutions, Inc., a leading national personal health coaching company, has released the results of new research showing that commonly held beliefs concerning the health status of employees enrolling in wellness education and counseling...
Biotechnology Key to Developing Sustainable Industries Says International Panel at 2008 BIO International Convention
SAN DIEGO-(Business Wire)-June 18, 2008 - Despite recent controversies over crop-based biofuels, biotechnology offers some of the best opportunities to create a more sustainable world, with applications as diverse as new sources of energy, new materials for industrial and consumer uses, and high...
Congress Celebrates 10 Years with Endorsements from Leading Professional Societies and Organizations
BARCELONA, Spain-(Business Wire)-June 18, 2008 - As it celebrates its 10th year, the ESMO International Symposium: 10th World Congress on Gastrointestinal Cancer(R) has received endorsements from 6 leading professional societies and organizations, solidifying the reputation of the Congress as the...
Aperio to Present at Jefferies Second Annual Healthcare Conference
VISTA, Calif.-(Business Wire)-June 18, 2008 - Aperio Technologies, Inc., the leading provider of digital pathology systems and services for the healthcare and life sciences industry, announced today that Dirk Soenksen, chief executive officer, will speak at Jefferies & Company Inc.'s...
EH&E Launches Interactive Discussion Forum for Healthcare Environment of Care Professionals
NEEDHAM, Mass., June 18 PRNewswire — EH&E, an environmental and engineering consulting firm for the healthcare industry, has launched "EHEConnect" — an interactive discussion forum dedicated to Environment of Care (EC) professionals — at http://www.eheconnect.com. "The...
Healthways Proves Effectiveness of Senior Fitness Program with QualityMetric Health Survey
LINCOLN, R.I., June 18 PRNewswire — Launched in 1997, the SilverSneakers(R) Fitness Program was created to encourage older adults to increase their level of physical activity. It is now the nation's leading fitness program aimed exclusively at older adults. The program is offered by...
New Report 'Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline Set To Offer Only Modest Improvements' Has Identified 104 Drugs in the NSCLC Pipeline, 15% of Which Are in Late-Phase Development
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets is forecast to achieve the highest level of sales, with $473m by 2017. The current late-phase pipeline is unlikely to satisfy the high level of unmet need in the treatment of NSCLC. However, pipeline drugs are still likely to...
PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China
SAN DIEGO, June 18 PRNewswire — PacificGMP and Pacific Biopharma Group (PBG) announced that they have signed a definitive merger agreement and will develop a cGMP (current good manufacturing practices) biologics contract manufacturing organization (CMO) in Taizhou, China. At...
Monique Tula Joins AAC As Director of Strategic Planning and Public Policy
BOSTON, June 18 PRNewswire-USNewswire — Monique Tula joins AIDS Action Committee of Massachusetts (AAC) as Director of Strategic Planning and Public Policy. Working with key stakeholders and focused on priorities to stop the spread of new HIV infections and improving the health of...
Santaris Pharma Appoints S0ren Tulstrup as New President & CEO
H0RSHOLM, Denmark-(Business Wire)-June 18, 2008 - Santaris Pharma A/S, the Danish biopharmaceutical company, announced today that S0ren Tulstrup, previously Vice President, Global Human Health at Merck & Co., Inc., has been appointed President & Chief Executive Officer, effective July 1...
Research and Markets: The Increasing Incidence and Severity of Nosocomial Infections Has Sparked an Interest in Preventive Strategies Such as Vaccination
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets has announced the addition of the "Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?" report to their offering. As the reimbursement status for the cost of hospital-acquired infections is under pressure by payors...
The Cost Of Running Trials Approaches 30% Of Pharmaceutical Companies' Entire Drug Development Budgets, However 75% Of Patient Studies Fail To Make Their Timelines
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets . Subsequently, some have now found out what works well and what doesn't. The audience seemed fascinated to learn by these experiences. The issue of public and patient perceptions of clinical trials was at the forefront of many...
China Yongxin Pharmaceuticals Updates Investors on Performance and Growth Prospects in Special Letter to Shareholders
CHANGCHUN, China & LOS ANGELES-(Business Wire)-June 18, 2008 - China Yongxin Pharmaceuticals Inc. (OTCBB: CYXN), a leading distributor and retailer of pharmaceuticals in Northeastern China, today released a Special Letter to Shareholders from Yongxin Liu, the Company's Chairman and CEO. The text...
Northwest Run/Walk for Epilepsy - Seattle
Saturday event in Seattle benefits people living with seizures SEATTLE, June 18 PRNewswire-USNewswire — The Epilepsy Foundation Northwest announces its 6th Annual Northwest Run/Walk for Epilepsy to be held this Saturday, June 21 in Seattle at Green Lake Park near the Aqua Theatre...
More than a Dozen Companion Diagnostic Tests are Approved for use in the United States and Guide the Prescription of Products in Oncology, Cardiovascular Disease and Infectious Diseases
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets has announced the addition of Decision Resources, Inc.'s new report "The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends" to their offering. This report offers a comprehensive analysis of the...
Advaxis' Dr. John Rothman to Present at the Bio International Convention in San Diego, CA
NORTH BRUNSWICK, N.J.-(Business Wire)-June 18, 2008 - Dr. John Rothman CEO of Advaxis Inc., (OTCBB: ADXS), a developmental biotechnology company, is scheduled to present at the BIO International Convention (BIO) today, Wednesday, June 18, 2008, at 1:00PM PDT in the GEN Theater. Dr. Rothman's...
HemoBioTech Chairman & CEO Arthur Bollon, Ph.D., to Present at the Bio International Convention in San Diego, CA
DALLAS-(Business Wire)-June 18, 2008 - Arthur Bollon, Ph.D., chairman & CEO of HemoBioTech, Inc. (OTCBB: HMBT), will present at the 2008 Biotechnology Industry Organization (BIO) International Convention in San Diego, CA tomorrow, June 19, 2008. Dr. Bollon's presentation is scheduled for 1:00 PM...
Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
WALTHAM, Mass., June 18 PRNewswire-FirstCall — Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman and CEO, and Jon Russell, Vice...
CVS/pharmacy Makes It Easier for Consumers to Save Money and Track Spending with Health Savings and Flexible Spending Accounts
WOONSOCKET, R.I., June 18 PRNewswire — According to a recent study(1), more than 6.1 million Americans are currently enrolled in health savings account (HSA)-eligible insurance plans, a 35 percent increase since last year. Consumers are increasingly turning to health savings and...
Cortex and Top Alberta Government Officials Meet to Discuss Progress on AMPAKINE Compounds at the 2008 Bio Conference
SAN DIEGO-(Business Wire)-June 18, 2008 - Cortex Pharmaceuticals, Inc.'s (AMEX: COR) senior management is scheduled to have a 90 minute breakfast meeting hosted by the Alberta's Premier Ed Stelmach and Doug Horner, Minister of Advanced Education and Technology (AET) at the 2008 Bio International...
Increasing Sales Productivity Through Superior Sales Force Performance Management
CHAPEL HILL, N.C., June 18 PRNewswire — To thrive in today's competitive and changing marketplace, sales force leaders need to understand that a winning sales performance doesn't just happen. Productive companies train, structure, deploy, and lead their sales forces, then measure the...
RXi Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
WORCESTER, Mass.-(Business Wire)-June 18, 2008 - RXi Pharmaceuticals Corporation (RXi) (Nasdaq: RXII), today announced that the Company's President and CEO Tod Woolf, Ph.D. will present a corporate overview at the Jefferies 2nd Annual Healthcare Conference in New York City on Wednesday, June 25...
CytRx Corporation to Present at the Jefferies 2nd Annual Healthcare Conference
LOS ANGELES-(Business Wire)-June 18, 2008 - CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that Steven A. Kriegsman, President and Chief Executive Officer, will be presenting at the Jefferies 2nd...
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Freda C. Lewis-Hall, M.D. as Executive Vice President, Medicines Development. Dr. Lewis-Hall joins Vertex from Bristol-Myers Squibb, Incorporated, and has...
PharmaNet Development Group to Present at the Jefferies 2nd Annual Healthcare Conference on Thursday June 26, 2008
PRINCETON, N.J.-(Business Wire)-June 18, 2008 - PharmaNet Development Group, Inc., (the "Company" or "PharmaNet") (NASDAQ: PDGI), today announced that Jeffrey P. McMullen, president and chief executive officer, will make a presentation on the Company at the Jefferies 2nd Annual Healthcare Conference...
Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex(TM) Program for Prostate Cancer Diagnosis and Staging
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today announced three presentations at the Society of Nuclear Medicine (SNM) 55th Annual Meeting on preclinical data supporting its Trofex program for the detection, staging and monitoring of...
Kerr Drug, KDI Health Solutions and HealthTrans Collaborate to Provide Unique Pharmacy Benefits Plan
RALEIGH, N.C.-(Business Wire)-June 18, 2008 - Two North Carolina companies, Kerr Drug and KDI Health Solutions, in partnership with HealthTrans, announce a new, first-of-its-kind, community-based pharmacy benefits plan, designed specifically as a solution for North Carolina employers. The...
Report: NIH and Global Health Research are a Major Boon to All State Economies
NIH research awards to states in 2007 created more than 350,000 new jobs, generated more than $18 billion in wages from those new jobs, and spurred more than $50 billion in business activity nationwide Report Says Flat Funding for NIH Threatens New Health Research, U.S. Medical Leadership, and State...
Lustgarten Foundation Announces 2009 Request for Proposals (RFP)
BETHPAGE, N.Y., June 18 PRNewswire — The Lustgarten Foundation for Pancreatic Cancer Research, the largest private foundation dedicated exclusively to supporting pancreatic cancer research, has announced its Year 2009 Request For Proposals (RFP) to identify promising research into...
Molecular Insight Pharmaceuticals, Inc. Reports Onalta(TM) Tissue Distribution Data Support Clinical Development Program
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) reported on two preclinical studies that demonstrated the potential of indium-111-edotreotide as an imaging tool to predict Onalta (yttrium-90-edotreotide) absorption in body tissues and to aid in...
ESMO Guideline Working Group Recommends Hyperthermia Therapy as Treatment Option for Soft Tissue Sarcoma Reports BSD Medical
SALT LAKE CITY-(Business Wire)-June 18, 2008 - BSD Medical Corp. (NASDAQ: BSDM) today reported that in the Annals of Oncology (Volume 19, Supplement 2, 2008), the European Society for Medical Oncology (ESMO) Clinical Treatment Guideline Working Group has published its relevant clinical treatment...
Enbrel(R) (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
THOUSAND OAKS, Calif.-(Business Wire)-June 18, 2008 - Amgen (NASDAQ:AMGN) announced that the supplemental Biologics License Application (sBLA) for ENBREL for the treatment of pediatric patients with chronic moderate to severe plaque psoriasis who have tried another therapy will be discussed today at...
Herborium Group, Inc. to Purchase the Proprietary Herbal Botanical Therapeutic(R) Formula for AcnEase(R)
TEANECK, N.J.-(Business Wire)-June 18, 2008 - Herborium Group, Inc. (OTC BB: HBRM), a botanical therapeutics(R) company that develops, licenses and markets novel botanical ingredients based medicinal products and related digital support content, today announced that it has entered into a purchase...
Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration Triggered by Genentech's IND Filing
BOTHELL, Wash.-(Business Wire)-June 18, 2008 - Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc. The milestone was triggered by Genentech's filing of an Investigational New Drug (IND...
Lux Biosciences to Present at Jefferies 2nd Annual Healthcare Conference
JERSEY CITY, N.J.-(Business Wire)-June 18, 2008 - Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Ulrich Grau, President and CEO, will present a company overview at the Jefferies 2nd Annual Healthcare Conference on...
Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion
SAN DIEGO, June 18 Xinhua-PRNewswire — Singapore has firmly established itself as a leading manufacturing hub in Asia with its strong track record, sophisticated infrastructure, superior IP protection and reliability. Its biomedical sciences manufacturing output expanded four-fold...
Study: Medicare Competitive Bidding Program Could Impede Seniors' Access to Diabetes Testing Supplies
Coalition Aims to Support and Educate Seniors WASHINGTON, June 18 PRNewswire-USNewswire — The new Medicare Durable Medical Equipment competitive bidding program that starts July 1 could make it more difficult for seniors to manage their diabetes care, according to a new analysis...
Verispan Reports: Nearly Half of Pharmaceutical Companies Surveyed Anticipate Change in Managed Care Sales Force in 2008
YARDLEY, Pa.-(Business Wire)-June 18, 2008 - Forty-five percent of the pharmaceutical companies surveyed in Verispan's newly released study, Strategic Advantage: A Competitive View of Managed Care and Long-Term Care Sales Forces, said they anticipate changes to their managed care sales force in...
Educational Services of America Names a New Senior VP of Operations
NASHVILLE, Tenn., June 18 PRNewswire — Educational Services of America (ESA) today announced Stephanie Martin has been appointed senior vice president of operations for College Living Experience (CLE), an ESA program that helps students with autism and other special needs attend...
Essential New Themes for Online Marketing and eDetailing
DUBLIN-(Business Wire)-June 18, 2008 - Research and Markets and its benefits, and the coordination and integration of e-marketing initiatives into traditional strategies improves, widespread support for the e-channel has yet to emerge. The e-approach is producing true, demonstrable results, yet...
Canopus BioPharma Strengthens Its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement with Wisconsin Alumni Research Foundation
LOS ANGELES-(Business Wire)-June 18, 2008 - Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer and addiction, today announced the signing of a licensing agreement...
Elixir Pharmaceuticals Announces Ghrelin Agonist Data Presentation at the Endocrine Society Annual Meeting
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - Elixir Pharmaceuticals, Inc., today announced that results from in-vivo preclinical studies with the Company's ghrelin agonist, EX-1314, were presented at the annual meeting of the Endocrine Society. EX-1314 is expected to enter human clinical testing...
National Health Partners Announces Landmark Union Deal
HORSHAM, Pa.-(Business Wire)-June 18, 2008 - National Health Partners, Inc. (OTCBB:NHPR), a leading provider of unique discount healthcare membership programs, announced today that it has been selected by a 5,000-member union as the health benefit program provider for all of the union's members. The...
Inspire Announces Webcast of Presentation at Piper Jaffray Europe Conference
DURHAM, N.C.-(Business Wire)-June 18, 2008 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO of Inspire, will present at the Piper Jaffray Europe Conference on Wednesday, June 25, 2008 at 10:40 am GMT in London, England. The webcast of...
ARIAD to Webcast Presentation at the Jefferies 2nd Annual Healthcare Conference
CAMBRIDGE, Mass.-(Business Wire)-June 18, 2008 - ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2nd Annual Healthcare Conference in New York, New York. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of...
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
NEW YORK-(Business Wire)-June 18, 2008 - Pfizer Inc announced today that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world's...
Pharmaceutical Pricing and Distribution in Japan Incorporates All Pricing Rule Changes That Came into Effect from April 2008
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets set by the government. Innovative new drugs receive price premiums while others are capped at the price of older entrants. Discounting to the trade is inescapable, but is punished by downward price revisions on a scale and...
Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
FORT LAUDERDALE, Fla., June 18 PRNewswire-FirstCall — Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that its wholly owned subsidiary, Kirk Pharmaceuticals, LLC (Kirk) during the past year has added Dollar General and...
Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb
PRINCETON, N.J., June 18 PRNewswire-FirstCall — Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its key product, MEDIHONEY(TM) Wound & Burn Dressing with Active Leptospermum Honey, has been used by clinicians at...
Core Informatics Deploys Core LIMS to Support Antibody Discovery at Fabrus
LA JOLLA, Calif., June 18 PRNewswire — Core Informatics, LLC. has deployed an installation of the Core LIMS to support Fabrus LLC, the first occupant of Pfizer's business incubator at the La Jolla Research and Development Center. Before Fabrus commenced laboratory operations, the...
The Snapshots Hungary Pharmaceuticals 2008 Report is out Now
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets Page 10 - Socio-Economic Data for Hungary Page 11 - Snapshots Sources for Further Research For more information visit: http://www.researchandmarkets.com/research/7259af/snapshots_hungary
HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
KING OF PRUSSIA, Pa., June 18 PRNewswire — HighPoint Solutions LLC, a premier provider of business-driven IT solutions, today announced that it has signed an agreement with a global specialty pharmaceutical company to design and implement the Model N Managed Care and Government...
HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
MADISON, N.J., June 18 PRNewswire-FirstCall — HemoCue(R) AB, a global point-of-care diagnostic test manufacturer and wholly owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that its HemoCue Albumin 201 System is the first quantitative point-of-care test...
Gerresheimer Discontinues Marginal Operations
DUSSELDORF, Germany, June 18 PRNewswire-FirstCall — - Sale of Consumer Healthcare Business - Concentration on Core Business of Pharmaceutics and Life Science Gerresheimer AG, the leading manufacturer of glass and plastic products for the pharma & life science industry, is selling...
ZymoGenetics to Webcast Presentation at Piper Jaffray London Conference
SEATTLE-(Business Wire)-June 18, 2008 - ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that Douglas E. Williams, Ph.D., President and Chief Scientific Officer, will provide an update on company activities at the Piper Jaffray Third Annual Europe Conference in London on Wednesday, June 25, 2008...
As Summer Heats Up, New Survey Reveals Need for Effective Sweat Treatments
NEW YORK, June 18 PRNewswire — As the thermometer rises, so does the humidity. For many, the humidity can be annoying, but for the nearly 8 million Americans who suffer from a treatable condition called hyperhidrosis(1), or excessive sweating, the humidity can be unbearable...
Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference
CHESHIRE, Conn., June 18 PRNewswire-FirstCall — Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Jefferies & Co. 2nd Annual Healthcare Conference in New York City at 4:15 p.m...
Philips Web Site Offers Seniors and Caregivers Tips and Techniques for Preventing Falls
ANDOVER, Mass., June 18 PRNewswire-FirstCall — Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced the launch of the website http://www.LearnNotToFall.com in response to the alarming rise in falls among seniors. Launched by Philips Lifeline, makers of the popular personal...
DATATRAK International, Inc. Receives Notice From Nasdaq
CLEVELAND, June 18 PRNewswire-FirstCall — DATATRAK International, Inc. (Nasdaq: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it received a letter on June 16, 2008, from The Nasdaq Stock Market...
Stroke is One of the Top Three Causes of Death and Its Incidence in the Seven Major Markets is Expected to Increase in the Next Ten Years
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets sales forecasts of late-stage pipeline drugs and examine their clinical and commercial potential. Key Topics Covered: -0- *T ABOUT US HEALTHCARE CHAPTER 1 EXECUTIVE SUMMARY CHAPTER 2 PIPELINE OVERVIEW AND DYNAMICS CHAPTER 3 PATIENT...
Covance to Present at the William Blair Growth Stock Conference
PRINCETON, N.J., June 18 PRNewswire-FirstCall — Covance Inc. (NYSE: CVD) today announced that it will present at the William Blair Growth Stock Conference on Thursday, June 19, 2008 at 3:30 pm (ET). Investors may access a live webcast of the presentation at http://www.covance.com...
The Pharmaceutical Industry is Leaving an Estimated US$25 Billion on the Shelf Every Year Through Lack of Patient Compliance
DUBLIN, Ireland-(Business Wire)-June 18, 2008 - Research and Markets http://www.researchandmarkets.com/research/a99980/keywordpharma_conf has announced the addition of the "KeywordPharma Conference Insights - Patient Compliance Europe" report to their offering. Doctors have probably been telling...
Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
BOSTON, June 18 PRNewswire-FirstCall — PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Wednesday, June 25, 2008, from 8:30 a.m. to 12:30 p.m. (EDT). All...
BioInvent and ThromboGenics Announce a Strategic Alliance with Roche for TB-403, A Novel Anti-Cancer Antibody
LUND, Sweden & LEUVEN, Belgium & BASEL, Switzerland-(Business Wire)-June 18, 2008 - BioInvent International AB (STO:BINV) and ThromboGenics NV (Euronext Brussels: THR) announce that they have entered into a license agreement with Roche (SWX: ROG) for their jointly developed anti-cancer agent...
GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
BRIDGEWATER, N.J. and NEW YORK, June 18 PRNewswire — GANIC Pharmaceuticals, a new specialty pharmaceutical company, today announced its launch backed by Warburg Pincus, the leading global private equity firm. Warburg Pincus has made an initial investment in GANIC from Warburg Pincus...
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
NEW YORK, June 18 PRNewswire — Danube Pharmaceuticals, Inc., a privately held biopharmaceutical company specializing in the commercial research and development of innovative drugs for ophthalmology, is pleased to announce the appointment of Dr. Barrett Katz, MD, MBA as its Chief...
Cyberonics to Present at Jefferies 2nd Annual Healthcare Conference
HOUSTON, June 18 PRNewswire-FirstCall — Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on Wednesday, June 25...
FlowCardia, Inc. Appoints Deborah DeFilippo CFO
SUNNYVALE, Calif., June 18 PRNewswire — FlowCardia, Inc., a medical device company developing endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, today announced the appointment of Deborah DeFilippo to the position of Chief Financial...
Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
NEW YORK, June 18 PRNewswire-FirstCall — Medicsight PLC (AIM: MDST), a subsidiary of MGT Capital Investments, Inc. (Amex: MGT) (the "Company"), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announced that data presented at...
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
REHOVOT, Israel and JERSEY CITY, New Jersey, June 18 /PRNewswire-FirstCall/ — Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today the advancement of three new diagnostic tests into its development pipeline. The...
Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
PT. RICHMOND, Calif., June 18 PRNewswire — Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President & Chief Executive Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on Wednesday, June 25, 2008 at 9:30 AM Eastern...
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
BIRMINGHAM, Ala., June 18 PRNewswire-FirstCall — BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that William P. Sheridan, MB BS, has been appointed Chief Medical Officer of BioCryst, effective July 1, 2008. Dr. Sheridan is a seasoned biotechnology professional, most recently...
Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards
WEST CONSHOHOCKEN, Pa., June 18 PRNewswire — Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, announced today that it has been recognized with five awards at the 14th Annual Communicator Awards. The Communicator Awards is the leading...
Pop! Technology Goes Growthink
LOS ANGELES, June 18 PRNewswire — Growthink, the leading Investment Banking and Business Development Services Firm to Emerging and Middle Market Enterprises, announced today that the Firm has been retained to raise $2.0 million in Series A capital for Pop! Technology, a creator of...
Nuvelo to Present at Jefferies 2nd Annual Healthcare Conference
SAN CARLOS, Calif., June 18 PRNewswire-FirstCall — Nuvelo, Inc. (Nasdaq: NUVO) today announced that Dr. Ted W. Love, the company's chairman and chief executive officer, will present at the Jefferies 2nd Annual Healthcare Conference on Wednesday, June 25, 2008, at 1:30 p.m. ET in New...
Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference
SUNNYVALE, Calif., June 18 PRNewswire-FirstCall — Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the Jefferies Healthcare Conference...
Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
LOS ANGELES, California, June 18 PRNewswire-FirstCall — Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from infectious disease, radiation sickness, cancer and addiction, today announced the signing...
BioMS Medical to present at Jefferies Healthcare Conference
EDMONTON, June 18 PRNewswire-FirstCall - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Jefferies 2nd Annual Healthcare Conference in New York. WHEN: Wednesday June...
Ikaria's INOflo (Nitric Oxide) for Inhalation to be Officially Approved in Japan
CLINTON, N.J., June 18 PRNewswire — Ikaria Holdings, Inc., through its subsidiary INO Therapeutics LLC, announced today that Japan's Ministry of Health, Labor, and Welfare's Council on Drugs and Food Sanitation (CDFS) has recommended approval of INOflo (nitric oxide) for inhalation...
SuperGen to Present at the Piper Jaffray Europe Conference on June 25, 2008
DUBLIN, Calif., June 18 PRNewswire-FirstCall — SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President...
The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
WHITE PLAINS, N.Y., June 18 PRNewswire — The Leukemia & Lymphoma Society (LLS) and Memgen jointly announced an agreement today to collaborate on a new Phase I clinical trial. The trial will use Memgen's ISF35, an active immunotherapy approach for treating chronic lymphocytic...
Nile Therapeutics Completes License Agreement for CU-NP, a Rationally Designed Natriuretic Peptide
SAN FRANCISCO, June 18 PRNewswire-FirstCall — Nile Therapeutics, Inc. (Nasdaq: NLTX), today announced that it has entered into a worldwide, exclusive license agreement with Mayo Clinic ("Mayo") for the rights to commercially develop CU-NP, a rationally designed natriuretic peptide...
Lundbeck Maintaining Presence in Alzheimer's Disease Market Through Strategic Agreement to Market Myriad Genetics' Flurizan
WALTHAM, Mass., June 18 PRNewswire — Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, reports that Lundbeck acquired European marketing rights to Myriad Genetics' Flurizan in May of 2008 in a timely move as its own...
Lexapro is the Leading Single Agent In First- and Second-Line Patient Share for the Treatment of Generalized Anxiety Disorder
WALTHAM, Mass., June 18 PRNewswire — Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Lexapro is the leading single agent used in anxiety therapy with 11.7 percent and 14.9 percent of first- and...
ARUP Laboratories Partners With Pathology Service Associates
SALT LAKE CITY, June 18 PRNewswire — ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today that it has entered into a business alliance with Pathology Service Associates, LLC...
Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
SAN DIEGO, June 18 PRNewswire-FirstCall — Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will present at the Jefferies 2nd Annual Healthcare Conference to be held...
China Sky One Medical, Inc. Obtains SFDA Approval to Produce Four New Drugs
HARBIN, China, June 18 Xinhua-PRNewswire-FirstCall — China Sky One Medical, Inc. (Amex: CSY) (''China Sky One'' or ''the Company''), a China-based manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic kit products, announced today that it has obtained...
BioSpace Launches EuroBio(TM) Online Community
MANASQUAN, N.J., June 18 PRNewswire — BioSpace, the world's leading online community for the bioscience industry, launched today its new online hotbed communities for the biotechnology, pharmaceutical and medical devices industries in Europe. EuroBio(TM) features dynamic informational...
Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
WINSTON-SALEM, N.C., June 18 PRNewswire — Pilot Therapeutics Holdings, Inc. today announced the relaunch of Pilot Therapeutics as Gene Smart(TM) Health. As an innovator in gene-based nutrition, Gene Smart(TM) Health uniquely combines breakthrough scientific innovation and an in-depth...
Radiation Oncology Pioneer Mark Carol, MD, Joins Xoft as Chief Medical Officer
SUNNYVALE, Calif., June 18 PRNewswire — Xoft, Inc., makers of the Axxent(R) Electronic Brachytherapy System, a proprietary technology platform designed to deliver localized, non-radioactive, isotope-free radiation treatment in minimally-shielded clinical settings, announced today that...
New Study: Pine Bark Significantly Reduces Menstrual Pain
HOBOKEN, N.J., June 18 PRNewswire — A new study reveals dysmenorrhea, a condition that causes extremely painful menstrual periods affecting millions of women each year, can be reduced naturally by taking Pycnogenol(R) (pic-noj- en-all), pine bark extract from the French maritime pine...
Key to Growth in Lifesciences Sector: Strategic Public-Private Collaboration
MUMBAI-(Business Wire)-June 18, 2008 - Lifesciences Research is a lengthy, complex and expensive process. Also, there is increasing pressure on pharmaceutical and biotech companies to reduce costs and time lines for product development. India has a huge network of research institutes and...
Nventa Develops Proprietary Vaccine Adjuvant
SAN DIEGO, June 18 PRNewswire-FirstCall — Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company has developed a proprietary vaccine adjuvant, Poly IC-Poly Arginine (Poly-ICR), that has broad potential for use in both therapeutic and prophylactic vaccines...
Genoptix Announces Participation at the Jefferies Second Annual Healthcare Conference
CARLSBAD, Calif., June 18 PRNewswire-FirstCall — Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the Jefferies Second Annual Healthcare Conference scheduled to take place on June 24 - 26, 2008. Douglas Schuling...
Somanetics Reports Record Net Revenues and Income Before Income Taxes for the Second Quarter of 2008
TROY, Mich., June 18 PRNewswire-FirstCall — Somanetics Corporation (Nasdaq: SMTS) today reported record net revenues of $12.7 million for the second quarter ended May 31, 2008, a 40 percent increase from $9.1 million in the same period of 2007. For the six months ended May 31, 2008...
Rigel to Present at Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 18 PRNewswire-FirstCall — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, will be presenting a company overview at the Jefferies 2nd Annual Healthcare Conference in...
Repligen Announces Share Repurchase Program
WALTHAM, Mass., June 18 PRNewswire-FirstCall — Repligen Corporation (Nasdaq: RGEN) today announced that its Board of Directors has authorized the repurchase of up to 1,250,000 shares of its common stock. Under the program Repligen may repurchase shares from time to time at prevailing...
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
GURGAON, Harayana, India and PRINCETON, N.J., June 18 PRNewswire — Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's...
No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
WASHINGTON, June 18 PRNewswire — Georgetown University, Gentag, Inc., and Science Applications International Corporation (SAIC, NYSE: SAI), have combined forces to develop a non-invasive method for glucose measurement. The three technology leaders agreed to combine their respective...
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
ROCKVILLE, Md., June 18 PRNewswire-FirstCall — EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the appointment of Mr. Thomas H. Bliss, Jr. as Senior Vice President...
Medarex to Present at the Jefferies Second Annual Healthcare Conference
PRINCETON, N.J., June 18 PRNewswire-FirstCall — Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the Jefferies Second Annual Healthcare Conference at 11:15 a.m. Eastern Time on Wednesday, June 25, 2008. The event will be webcast live and will be...
The Quantum Group Announces Second Quarter Financial Results for Fiscal Year 2008
WELLINGTON, Fla., June 18 PRNewswire-FirstCall — The Quantum Group, Inc. (Amex: QGP) ( www.QuantumMD.com ) announced today its financial results for the second quarter of fiscal 2008 ended April 30, 2008. For the period ended April 30, 2008, the Company reported an increase in...
StayWell Custom Communications Announces Strategic Alliance With HealthMedia
EVANSTON, Ill., June 18 PRNewswire — Custom print and online health communications publisher StayWell Custom Communications (SCC), a division of MediMedia USA, has announced a strategic alliance with HealthMedia, Inc. to bring its clients the industry-leading, innovative online behavior...
ATS Medical to Participate at the Piper Jaffray Europe Conference
MINNEAPOLIS, June 18 PRNewswire-FirstCall — ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, today announced that it will participate at the Piper Jaffray Europe Conference in London, England on Wednesday, June 25, 2008...
AutoGenomics Receives a Key European Patent for HPV Detection
CARLSBAD, Calif., June 18 PRNewswire — AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has been issued a key European patent for Human papillomavirus. Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims...
Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
SOUTH SAN FRANCISCO, Calif., June 18 PRNewswire-FirstCall — Monogram Biosciences, Inc., (Nasdaq: MGRM) announced today that the Company has signed an agreement with Gilead Sciences, Inc. to provide resistance testing and consultative services for Gilead's Elvitegravir Phase III studies...
Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
IRVINE, Calif., June 18 PRNewswire-FirstCall — Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products for cardiac revascularization today announced an upcoming scientific presentation that describes the use of combining transmyocardial...
Maryland Dermatologists Set New Records in Sun Safety Outreach at Popular LPGA Tournament
HAVRE DE GRACE, Md., June 18 PRNewswire — Amidst sweltering temperatures and huge crowds of golf fans, a dedicated team of volunteers representing the Women's Dermatologic Society (WDS) broke its national records for "Play Safe in the Sun," a 3-year community outreach service in...
Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
COPENHAGEN, June 18 PRNewswire — Nuevolution A/S today announced that it has entered into a drug discovery collaboration with Merck & Co. Inc. Nuevolution will apply its proprietary Chemetics(R) drug discovery technology to identify novel small molecule leads against several drug...
Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim
NICE, France, June 18 PRNewswire — - The new Lumax 540 technologies together with BIOTRONIK Home Monitoring(R) offer remote, wireless advanced patient management that provides daily protection for patients with life-threatening arrhythmias. BIOTRONIK GmbH & Co KG, the pioneer in...
Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
SEATTLE, June 18 PRNewswire-FirstCall — On Wednesday, June 18, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC; MTA) management team will host a conference call to discuss agreement with Bayer Schering...
CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
SEATTLE, June 18 PRNewswire-FirstCall — Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC; MTA) announced today an agreement with Bayer Schering Pharma to gain access to Bayer's phase III Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent Trial, FIT data. CTI expects that the data...
ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire-FirstCall/ — ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have entered into a license agreement with Roche (SWX: ROG) for their jointly developed...
Cytopia To Present Data on FMS Program With Anticancer Potential
MELBOURNE, Australia, June 18 PRNewswire — Cytopia Limited (ASX: CYT) will present details of its FMS drug discovery and development program at the Protein Kinase Targets conference, a leading conference for breakthrough scientific data on new kinase inhibitory drugs. This conference...
Synthetic Blood International, Inc. Shareholders Approve Name Change and Reincorporation
COSTA MESA, Calif.-(Business Wire)-June 18, 2008 - Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that the company's shareholders have approved the proposals put before them at a special shareholders meeting that was held today. The proposals include changing the name of the...
Puerto Rico Adopts New Economic Incentives Law, Increasing Benefits for Life Sciences Companies
SAN DIEGO-(Business Wire)-June 17, 2008 - Armed with a sweeping new package of incentives for investment by companies in life sciences and other industries, Puerto Rico Governor Anibal Acevedo-Vila arrived at BIO 2008 to meet with corporate executives and their advisors to discuss the advantages...
Alcon Announces Second Quarter 2008 Financial Release and Conference Call Dates
HUENENBERG, Switzerland-(Business Wire)-June 17, 2008 - Alcon, Inc. (NYSE: ACL), the world's leading eye care company, will report on its second quarter financial results for the period ended June 30, 2008 after the market close on Wednesday, July 23, 2008. Management of the company will host a...
Magnifi Group and The Spine Arthroplasty Society (SAS) Partner to Rollout Interactive Educational Program for US Members
SAN DIEGO-(Business Wire)-June 17, 2008 - Magnifi Group, Inc., considered by many industry observers to be one of the most innovative educational and marketing-driven technology companies within the medical device industry, announced today a joint venture with The Spine Arthroplasty Society (SAS...
AMA Adopts New Policies at Annual Meeting
CHICAGO, June 17 PRNewswire-USNewswire — The American Medical Association (AMA), the nation's largest physician group, voted today at its Annual Meeting to adopt the following new policies. APPROPRIATE ASPIRIN USE FOR PREVENTION OF HEART DISEASE AND STROKE: Six trials, involving more...
AMA Adopts New Public Health Policies at Annual Meeting
CHICAGO, June 17 PRNewswire-USNewswire — The American Medical Association (AMA), the nation's largest physician organization, voted today at its Annual Meeting to adopt the following new public health policies. APPROPRIATE SUPPLEMENTATION OF VITAMIN D: The current Reference Intake...
AMA Adopts Strategies to Help Address Medical Student Debt
New Policies Aim to Help Relieve Physician Shortage CHICAGO, June 17 PRNewswire-USNewswire - The American Medical Association (AMA) today adopted new policy to help address the increasing medical student debt burden at its Annual Meeting. Over the last 15 years, the cost of a public school...
Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates
CHICAGO, June 17 PRNewswire-USNewswire — The American Medical Association (AMA) announced today the re-election of Andrew W. Gurman, M.D., a Pennsylvania orthopaedic hand surgeon, to his second consecutive term as vice speaker of the AMA House of Delegates. In this position, Dr. Gurman...
Panacos Announces Results of Bevirimat Prospective Study, which Confirm Patient Response Predictors
WATERTOWN, Mass.-(Business Wire)-June 17, 2008 - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) today announced the completion of a Phase 2b prospective study of bevirimat in treatment-experienced and treatment-naive patients that confirms the recently discovered factors that predict response to...
PharMerica To Present at Jefferies 2nd Annual Healthcare Conference
LOUISVILLE, Ky.-(Business Wire)-June 17, 2008 - PharMerica Corporation (NYSE: PMC), the second largest institutional pharmacy services company in the United States, today announced that Michael J. Culotta, Executive Vice President and Chief Financial Officer, will make a presentation regarding the...
Bill Allowing Medical Privacy Intrusion Fails in Sacramento; Anti-Privacy Bill by Auto Insurers Faces Vote Wednesday
Consumer Watchdog Hails Assembly Push Against Sale of Patients' Prescription Information to Marketers; "Big Pharma's Lobbying Steamroller Is Out of Gas," Says Advocate. SACRAMENTO, Calif., June 17 PRNewswire-USNewswire — A bill allowing marketers hired by drug companies to secretly...
SupplyScape Selected by Sciele Pharma for Transaction and Product Security
WOBURN, Mass.-(Business Wire)-June 17, 2008 - SupplyScape Corporation, the leading provider of software to secure the safety and value of the pharmaceutical supply chain, today announced that Sciele(R) Pharma, Inc. has selected SupplyScape's E-Pedigree(TM) data management solution to manage...
FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
HORSHAM, Pa., June 17 PRNewswire — Centocor, Inc. announced today that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the U.S. Food and Drug Administration (FDA) has unanimously recommended the approval of ustekinumab, a new subcutaneous, investigational biologic...
IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008
NORTH HOLLYWOOD, Calif., June 17 PRNewswire-FirstCall — IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today reaffirmed its guidance for full year 2008 revenue to be in the range of $239 million to $245 million and full year...
AMA Inaugurates Dr. Nancy Nielsen as President
New York physician becomes the AMA's second woman president CHICAGO, June 17 PRNewswire-USNewswire — Nancy H. Nielsen, M.D., Ph.D., a board-certified internist from Buffalo, N.Y., was inaugurated today as the 163rd president of the American Medical Association (AMA), the nation's...
U.S. EPA Licenses Simulations Plus' ADMET Predictor(TM) Software
LANCASTER, Calif.-(Business Wire)-June 17, 2008 - Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Environmental Protection Agency for its ADMET Predictor(TM...
IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook
NORTH HOLLYWOOD, Calif., June 17 PRNewswire-FirstCall — IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today announced that it continues to experience favorable trends in patient encounters and expects second quarter 2008 net...
IPC The Hospitalist Company, Inc. Files Registration Statement for Proposed Offering
NORTH HOLLYWOOD, Calif., June 17 PRNewswire-FirstCall — IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission in connection...
PartsSource Given 2008 'World Class Customer Service' Award for Second Straight Year
AURORA, Ohio, June 17 PRNewswire — PartsSource, the nation's leading supplier of replacement medical repair parts for hospital equipment, has won its second straight "World Class Customer Service" award for Northern Ohio. This year recognized PartsSource for its Service Brand Promise...
Healthation CEO Appoints New Senior Vice President of Business Development
DARIEN, Ill., June 17 PRNewswire — Healthation CEO Scott Kornhauser announced the appointment of Bryan Hebert as Senior Vice President of Business Development today. Mr. Hebert was a former consulting partner with over 18 years of experience in sales of complex solutions in the...
Accentia Reports on Multiple Sclerosis Study: Revimmune(R) Shows Unprecedented Results in Reducing Disability and Improving Functions
TAMPA, Fla.-(Business Wire)-June 17, 2008 - Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that researchers from Johns Hopkins University have published encouraging results from a two-year study evaluating the treatment of aggressive relapsing-remitting multiple sclerosis with...
MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
WARRENDALE, Pa., June 17 PRNewswire — MEDRAD, INC., announced today that it received FDA 510(k) clearance for a new Fluorodeoxyglucose (FDG) Infusion System for Positron Emission Tomography/Computed Tomography (PET/CT) imaging procedures. The new Intego(TM) PET Infusion System is the...
Commonwealth Biotechnologies Expands Presence into Japan with Opening of Tokyo Office
RICHMOND, Va.-(Business Wire)-June 17, 2008 - Commonwealth Biotechnologies, Inc. (CBI) (Nasdaq:CBTE) today announced its expansion into Japan through Venturepharm (Asia), with the opening of a new Tokyo office and appointment of Mikio Taniguchi as regional business development manager. The new...
New Technology May Prevent Vitamin B12 Deficient Seniors, Vegetarians and Anemics from Needing Injections
TORONTO-(Business Wire)-June 17, 2008 - For those patients who receive the nearly 40 million intramuscular injections per year to treat their B12 deficiency, a new oral option may soon exist. According to the National Institutes of Health, vitamin B12 deficiency can lead to a wide spectrum of...
Vyteris, Inc. Announces Completion of Reverse Stock Split and New Trading Symbol
FAIR LAWN, N.J.-(Business Wire)-June 17, 2008 - Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system, announced implementation of a 1 for 15 reverse split of the company's common stock, as well as the designation of a new trading symbol by...
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
SAN DIEGO, June 17 PRNewswire-FirstCall — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's...
Blue Cross Blue Shield Plans Post 18.2% Decline in Operating Earnings in 2007
PHILADELPHIA, June 17 PRNewswire — Sherlock Company reported in its PULSE research publication that Blue Cross Blue Shield Plans posted a 18.2% decline in operating earnings as revenues increased by 7.4% in 2007. Insured membership decreased by 1.4% to 51.5 million as ASO revenues...
Johnson & Johnson and American Red Cross Announce Resolution of Lawsuit
NEW BRUNSWICK, N.J., June 17 PRNewswire-FirstCall — Johnson & Johnson and the American Red Cross are pleased to announce resolution of the litigation over the Red Cross emblem. Both organizations have used the Red Cross emblem for over 100 years consistent with their respective...
VA Statement on Smoking Cessation Research Program
WASHINGTON, June 17 PRNewswire-USNewswire — Reports in the news media today that the Department of Veterans Affairs (VA) is testing drugs on war veterans are inaccurate and misleading. VA conducts extensive and often groundbreaking, evidence-based research nationwide to discover better...
High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance
CHAPEL HILL, N.C., June 17 PRNewswire — Across industry sectors, sales drive profits. And high-performing sales groups across industries share common operational, strategic and time management practices, according to benchmarking research from research and consulting firm Best...
Best Practices: Achieving Excellence in Staffing and Recruiting Methods
CHAPEL HILL, N.C., June 17 PRNewswire — The business of recruiting university students and new graduates is highly competitive today, especially in technology industries that rely on this talent pool to refresh the workforce with vital new knowledge and skills. Yet many companies...
Saladax Biomedical's 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
BETHLEHEM, Pa., June 17 PRNewswire — Saladax Biomedical, a company specializing in chemotherapy therapeutic drug monitoring, today announced CE mark registration in the European Union (EU) for its 5-FU Personalized Chemotherapy Management (PCM(R)) assay on the Olympus AU400 Clinical...
Berkeley Premium Nutraceuticals Celebrates 3 Years of Excellent Customer Service
CINCINNATI, June 17 PRNewswire — Berkeley Premium Nutraceuticals, the nation's largest direct-marketing nutraceutical marketer, recently celebrated 3 years of excellent customer service. Berkeley management's constant efforts to improve operations pay off as they enjoy company-wide...
Thought Leaders Discuss Positive Outlook for Bapineuzumab in Alzheimer's Disease in MedPredict Report
SCOTTSDALE, Ariz., June 17 PRNewswire — MedPredict has published a new report designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area. The report, entitled "Thought Leader Insight...
CIT GAP Funds Invests in OTraces, Inc.
Company offers more accurate blood tests for breast, ovarian cancers HERNDON, Va., June 17 PRNewswire-USNewswire — The Center for Innovative Technology (CIT), a state-chartered non-profit, announced today that its GAP BioLife Fund, part of the successful GAP Family of Funds, made a...
HUYA Bioscience Int'l Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
SAN DIEGO, June 17 PRNewswire — Bio International Convention 2008 452-3771 amyeberry@comcast.net juliet@travispr.com SOURCE HUYA Bioscience International
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
MARIETTA, Ga., June 17 PRNewswire — Solvay Pharmaceuticals, Inc. announced today that a new analysis of pivotal study data conducted by the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center showed that initial treatment response of hypogonadal men with...
Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
BEDMINSTER, N.J., June 17 PRNewswire — New data from a 12-month, international, multi-center study showed that treatment for low testosterone with Tostran(R), a topical, metered dose 2% testosterone gel, significantly improves insulin sensitivity and sexual function among hypogonadal...
Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference
IRVINE, Calif., June 17 PRNewswire-FirstCall — Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the 18th Annual Wachovia Nantucket Equity Conference at the White Elephant...
MAQUET Moves Manufacturing of Cardiovascular Products to Award-Winning New Jersey Facility
SAN JOSE, Calif., June 17 PRNewswire — MAQUET Cardiovascular LLC today announced that it will move manufacturing of its endoscopic vessel harvesting and clampless beating heart bypass product lines to its Wayne, New Jersey plant. The MAQUET facility in New Jersey has been recognized...
Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance
New trend findings of 'underinsured' patients based on successful management of nearly 45,000 cases by national, non-profit Patient Advocate Foundation in 2007 NEWPORT NEWS, Va., June 17 PRNewswire-USNewswire — Patient Advocate Foundation (PAF) — a national non-profit organization...
Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York
MELVILLE, N.Y., June 17 PRNewswire-FirstCall — Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's leading provider of comprehensive home health services, announced today that it is scheduled to present from 1:00 to 1:30 p.m. ET, Tuesday, June 24, 2008 at the Jefferies 2nd Annual...
Search Our News Using Google Search
Can't find what you want? Try using Google: